Results 11 to 20 of about 24,707 (237)
Increased Recall of Negative Memories Following Initial Methylphenidate Administration in a 6-Year-Old Boy With ADHD: A Case Report. [PDF]
Neuropsychopharmacol RepAn initial dose of 18 mg of Methylphenidate Hydrochloride Extended‐Release Tablets led to increased recall of negative life events in a 6‐year‐old child with ADHD. The increased recall of negative life events represents a time‐limited symptom rather than a persistent phenomenon.
Xiang Q +5 more
europepmc +2 more sources
Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000-24: analysis of NCIS data. [PDF]
Med J AustMedical Journal of Australia, Volume 222, Issue 5, Page 259-261, March 2025.
Darke S +4 more
europepmc +2 more sources
Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets
Swiss Medical Weekly, 2011 BACKGROUND:Non-medical use of methylphenidate is increasing. Little is known about potential acute medical complications associated with recreational use of methylphenidate.
Swiss Medical Weekly
doaj +1 more source
Methylphenidate and pregnancy [PDF]
British Journal of Clinical Pharmacology, 2014 I appreciate the paper by Bolea-Alamanac et al. 1 on the use of methylphenidate in pregnancy and lactation. I would like to point the interested reader towards another recent review on this subject 2. We documented at least 180 first trimester exposed cases (excluding case stories and the case series referred to by Bolea-Alamanac et al.
openaire +4 more sources
Methylphenidate use and school performance among primary school children: a descriptive study
BMC Psychiatry, 2017 Background There is no conclusive evidence that stimulants have beneficial effects on major associated outcome parameters, particularly school performance.
Jurjen van der Schans +6 more
doaj +1 more source
Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
Frontiers in Behavioral Neuroscience, 2022 BackgroundDespite widespread use of stimulants to treat ADHD, individual responses vary considerably and few predictors of response have been identified.
Anne B. Arnett +4 more
doaj +1 more source
Pharmaceuticals, 2021 Methylphenidate is one of the most widely used oral treatments for attention-deficit/hyperactivity disorder (ADHD). The drug is mainly absorbed in the small intestine and has low bioavailability.
Julia Aresti-Sanz +4 more
doaj +1 more source
Prevalence of methylphenidate use by university students in Campos dos Goytacazes, RJ
Vértices, 2014 Methylphenidate is a central nervous system stimulant commonly prescribed for children with Attention Deficit Hyperactivity Disorder. The aim of this study was to identify the prevalence of methylphenidate users among college students, as well as the ...
Fernanda Fraga Pessanha +1 more
doaj +1 more source
Journal of Research in Pharmacy Practice, 2014 Objective: The aim of the current study was to determine various aspects of methylphenidate adverse reactions in children with attention deficit-hyperactivity disorder (ADHD) in Iran.
Zahra Khajehpiri +5 more
doaj +1 more source
Neuropsychopharmacology Reports, 2018 Aim Attention‐deficit/hyperactivity disorder is a heterogeneous neurobiological disorder that is characterized by inattention, impulsivity, and an increase in motor activity.
Soichiro Ide +6 more
doaj +1 more source